Blood · 1995 · 64 citations · 26 references
Life SciencesMolecular BiologyMolecular GeneticsCancer GeneticsMolecular OncologyNeoplasiaAlternative SplicingCancer CytogeneticsCancer Molecular DiagnosticsNoncoding Rna TranscriptomicsRna SplicingCancer-associated SplicingOncogenic SplicingPolymerase Chain Reaction (Pcr) DiagnosisSplice Site Variant InterpretationSplice-site Variant DetectionSplicing Defect AnalysisTranscripts
As acute nonlymphocytic leukemia (ANLL) with inv(16) (p13q22) or t(16;16)(p13;q22) has been shown to result from the fusion of transcription factor subunit core binding factor (CBFB) to a myosin heavy chain (MYH11), we sought to design methods to detect this rearrangement using reverse transcriptase-polymerase chain reaction (RT-PCR). In all of 27 inv(16)(p13q22) and four t(16;16)(p13;q22) cases tested, a chimeric CBFB-MYH11 transcript coding for an in-frame fusion protein was detected. In a more extensive RT-PCR analysis with different primer pairs, we detected a second new chimeric CBFB-MYH11 transcript in 10 of 11 patients tested. The CBFB-MYH11 reading frame of the second transcript was maintained in one patient but not in the others. We show that the different CBFB-MYH11 transcripts in one patient arise from alternative splicing. Translation of the transcript in which the CBFB-MYH11 reading frame is not maintained leads to a slightly truncated CBFB protein.
26
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Pu Liu, Susan A. Tarlé, A K Hajra et al. · Science · 1993 · 743 citations
E. Ogawa, Masato Maruyama, Hiroshi Kagoshima et al. · Proceedings of the National Academy of Sciences · 1993 · 614 citations